Salinosporamides and Methods for Use Thereof
AssigneeThe Regents of the University of California
InventorsWilliam Fenical, Paul Jensen, Tracy Mincer, Robert H. R. Feling
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Regents of the University of California
InventorsWilliam Fenical, Paul Jensen, Tracy Mincer, Robert H. R. Feling
Estimating the term…
The present invention is based on the discovery that certain fermentation products of the marine actinomycete strains CNB392 and CNB476 are effective inhibitors of hyperproliferative mammalian cells. The CNB392 and CNB476 strains lie within the family Micromonosporaceae, and the generic epithet Salinospora has been proposed for this obligate marine group. The reaction products produced by this strain are classified as salinosporamides, and are particularly advantageous in treating neoplastic disorders due to their low molecular weight, low IC50 values, high pharmaceutical potency, and selectivity for cancer cells over fungi.
An isolated compound having the structure (I):
A pharmaceutical composition comprising an effective amount of a pharmaceutically acceptable carrier and an effective amount of a compound having the structure:
Dependencies are inferred from the claim text.